Device delivers drugs to brain via remote control​​

Device delivers drugs to brain via remote control​​

A team of researchers, including neuroscientists from Washington University School of Medicine in St. Louis, has developed a wireless device the width of a human hair that can be implanted in the brain and activated by remote control to deliver drugs to brain cells. The technology, demonstrated for the first time in mice, one day may be used to treat pain, depression, epilepsy and other neurological disorders in people by targeting therapies to specific brain circuits.
New findings hint toward reversing hearing loss

New findings hint toward reversing hearing loss

Studying mice, scientists at Washington University School of Medicine in St. Louis have identified two signaling molecules that are required for the proper development of a part of the inner ear called the cochlea. The study contributes to the understanding of inner ear development, a first step toward the goal of being able to recover lost hearing.

Surgery embraces diversity training

Faculty and staff in the plastic and reconstructive surgery, urologic surgery and public health sciences divisions in the Department of Surgery at Washington University School of Medicine in St. Louis have completed all four levels of training offered by the medical school’s diversity and inclusion team.
Drug-resistant bacteria possess natural ability to become vulnerable to antibiotics​​​

Drug-resistant bacteria possess natural ability to become vulnerable to antibiotics​​​

Infections with one of the most troublesome and least understood antibiotic-resistant “superbugs” are increasing at alarming rates, particularly in health-care settings. But by studying A. baumannii, a frequent cause of difficult-to-treat infections in hospitals,  researchers have identified a naturally occurring​ process that restores its vulnerability to antibiotics.
Siteman Cancer Center earns highest rating from federal cancer institute​​​​​​​​​

Siteman Cancer Center earns highest rating from federal cancer institute​​​​​​​​​

The National Cancer Institute (NCI) has awarded Siteman Cancer Center​ at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis an “exceptional” rating, based on a rigorous review of Siteman’s research programs. The rating is the highest possible by the NCI, the principal federal institute that funds cancer research.
Older Stories